Clinical Trial Update: Clinical Study of AK159 in Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and pharmacokinetics of AK159 in healthy postmenopausal women with osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• AK159

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED